최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기융합정보논문지 = Journal of Convergence for Information Technology, v.10 no.11, 2020년, pp.240 - 250
신경아 (신성대학교 임상병리과) , 김은재 (서울대병원 의학연구혁신센터 산부인과)
The purpose of this study was to investigate the relationship between serum uric acid levels, insulin resistance and components of metabolic syndrome. It was conducted on 4,428 adults over the age of 20 who had undergone health checkups at a general hospital in Gyeonggi-do from June 2018 to May 2020...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Y. He et al. (2006). Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. Journal of the American College of Cardiology, 47(8), 1588-1594. DOI : 10.1016/j.jacc.2005.11.074
M. H. Kim et al. (2020). The change of metabolic syndrome prevalence and its risk factors in Korean adults for decade: Korea National Health and Nutrition Examination Survey for 2008-2017. Korean Journal of Family Practice, 10(2), 44-52. DOI : 10.21215/kjfp.2020.10.1.44
B. Isomaa et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4), 683-689. DOI : 10.2337/diacare.24.4.683
A. Galassi, K. Reynolds & J. He. (2006). Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. American Journal of Medicine, 119(10), 812-819. DOI : 10.1016/j.amjmed.2006.02.031
E. S. Ford, M. B. Schulze, T. Pischon, M. M. Bergmann, H. G. Joost & H. Boeing. (2008). Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study. Cardiovascular Diabetology, 12(7), 35. DOI : 10.1186/1475-2840-7-35
K. Esposito, P. Chiodini, A. Colao, A. Lenzi & D. Giugliano. (2012). Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care, 35(11), 2402-2411. DOI : 10.2337/dc12-0336
J. Zhou et al. (2013). Association between metabolic syndrome and osteoporosis: a meta-analysis. Bone, 57(1), 30-35. DOI : 10.1016/j.bone.2013.07.013
T. W. Yoo et al. (2005). Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circulation Journal, 69(8), 928-933. DOI : 10.1253/circj.69.928
B. Liu et al. (2011). The prevalence of hyperuricemia in China: a meta-analysis. BioMed Central Public Health, 27(11), 832. DOI : 10.1186/1471-2458-11-832
E. S. Ford, C. Li, S. Cook & H. K. Choi. (2007). Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation, 15(19), 2526-2532. DOI : 10.1161/CIRCULATIONAHA.106.657627
S. Furukawa et al. (2004). Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation, 114(12), 1752-1761. DOI : 10.1172/JCI21625
J. Fang & M. H. Alderman. (2000). Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. Journal of the American Medical Association, 283(18), 2404-2410. DOI : 10.1001/jama.283.18.2404
M. J. Bos, P. J. Koudstaal, A. Hofman, J. C. M. Witteman & M. M. B. Breteler. (2006). Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke, 37(6), 1503-1507. DOI : 10.1161/01.STR.0000221716.55088.d4
K. Nagahama, K. Iseki, T. Inoue, T. Touma, Y. Ikemiya & S. Takishita. (2004). Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertension Research, 27(4), 227-233. DOI : 10.1291/hypres.27.227
S. Ohno et al. (2018). Recovery of Endothelial Function after Minor-to-Moderate Surgery Is Impaired by Diabetes Mellitus, Obesity, Hyperuricemia and Sevoflurane-Based Anesthesia. International Heart Journal, 59(3), 559-565. DOI : 10.1536/ihj.17-143
Z. Soltani, K. Rasheed, D. R. Kapusta & E. Reisin. (2013). Potential role of uric acid in metabolic syndrome, hypertension, kidney injury, and cardiovascular diseases: is it time for reappraisal? Current Hypertension Reports, 15(3), 175-181. DOI : 10.1007/s11906-013-0344-5
A. Costa, I. Iguala, J. Bedini, L. Quinto & I. Conget. (2002). Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism, 51(3), 372-375. DOI : 10.1053/meta.2002.30523
A. Onat et al. (2006). Serum uric acid is a determinant of metabolic syndrome in a population-based study. American Journal of Hypertension, 19(10), 1055-1062. DOI : 10.1016/j.amjhyper.2006.02.014
R. L. Borges, A. B. Ribeiro, M. T. Zanella & M. C. Batista. (2010). Uric acid as a factor in the metabolic syndrome. Current Hypertension Reports, 12(2), 113-119. DOI : 10.1007/s11906-010-0098-2
S. P. Hong et al. (2008). Relationship between serum uric acid level and metabolic syndrome according to gender. Korean Circulation Journal, 38(3), 152-160. DOI : 10.4070/kcj.2008.38.3.152
E. Adnan, I. A. Rahman & H. P. Faridin. (2019). Relationship between insulin resistance, metabolic syndrome components and serum uric acid. Diabetes & Metabolic Syndrome, 13(3), 2158-2162. DOI : 10.1016/j.dsx.2019.04.001
L'. Cibickova, K. Langova, H. Vaverkova, V. Kubickova & D. Karasek. (2017). Correlation of uric acid levels and parameters of metabolic syndrome. Physiological Research, 66(3), 481-487. DOI : 10.33549/physiolres.933410
D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher & R. C. Turner. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. DOI : 10.1007/BF00280883
S. Lee et al. (2006). Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults. Journal of Korean Medical Science, 21(4), 695-700. DOI : 10.3346/jkms.2006.21.4.695
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). The Journal of the American Medical Association, 285(19), 2486-2497. DOI : 10.1001/jama.285.19.2486
World Health Organization. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia.
H. Choi et al. (2016). Serum uric acid concentration and metabolic syndrome among elderly Koreans: The Korean Urban Rural Elderly (KURE) study. Archives of Gerontology and Geriatrics, 64, 51-58. DOI : 10.1016/j.archger.2016.01.005
L. B. Salaroli, M. Cattafesta, M. D. C. B. Molina, E. Zandonade & N. S. Bissoli. (2017). Insulin resistance and associated factors: a cross-sectional study of bank employees. Clinics (Sao Paulo, Brazil), 72(4), 224-230. DOI : 10.6061/clinics/2017(04)06
S. O. V. Nunes et al. (2014). Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence. Psychiatric Genetics, 24(3), 87-93. DOI : 10.1097/YPG.0000000000000023
A. M. Johnson & J. M. Olefsky. (2013). The origins and drivers of insulin resistance. Cell, 152(4), 673-684. DOI : 10.1016/j.cell.2013.01.041
N. Ali et al. (2020). Association between serum uric acid and metabolic syndrome: a cross-sectional study in Bangladeshi adults. Scientific Reports, 10(1), 7841. DOI : 10.1038/s41598-020-64884-7
H. Sumiyoshi, Y. Ohyama, K. Imai, M. Kurabayashi, Y. Saito & T. Nakamura. (2019). Association of uric acid with incident metabolic syndrome in a Japanese general population. International Heart Journal, 60(4), 830-835. DOI : 10.1536/ihj.18-444
Y. Q. Fu et al. (2017). Positive association between metabolic syndrome and serum uric acid in Wuhan. Asia Pacific Journal of Clinical Nutrition, 26(2), 343-350. DOI : 10.6133/apjcn.012016.06
C. F. Kuo, L. C. See, K. H. Yu, I. J. Chou, M. J. Chiou & S. F. Luo. (2013). Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford), 52(1), 127-134. DOI : 10.1093/rheumatology/kes223
S. Ciarla et al. (2014). Serum uric acid levels and metabolic syndrome. Archives of Physiology and Biochemistry, 120(3), 119-122. DOI : 10.3109/13813455.2014.924145
M. Abbasian, H. Ebrahimi, M. Delvarianzadeh, P. Norouzi & M. Fazli. (2016). Association between serum uric acid (SUA) levels and metabolic syndrome (MetS) components in personnel of Shahroud University of Medical Sciences. Diabetology & Metabolic Syndrome, 10(3), 132-136. DOI : 10.1016/j.dsx.2016.01.003
Z. Zhang, L. Bian & Y. Choi. (2012). Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. Angiology, 63(6), 420-428. DOI : 10.1177/0003319711423806
G. Mercuro et al. (2004). Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. American Journal of Cardiology, 94(7), 932-935. DOI : 10.1016/j.amjcard.2004.06.032
G. Wu & C. J. Meininger. (2009). Nitric oxide and vascular insulin resistance. Biofactors, 35(1), 21-27. DOI : 10.1002/biof.3
R. Meshkani, M. Zargari & B. Larijani. (2011). The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects. Acta Diabetologica, 48(1), 79-88. DOI : 10.1007/s00592-010-0231-3
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.